Real-world clinical outcomes of treatment with brodalumab in patients with moderate-to-severe psoriasis: a retrospective, 24-month experience from four academic dermatology centers in Greece-Reference-Cited by-同舟云学术

Real-world clinical outcomes of treatment with brodalumab in patients with moderate-to-severe psoriasis: a retrospective, 24-month experience from four academic dermatology centers in Greece

Published:2022-08-23 Issue:7 Volume:33 Page:3053-3059
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Papadavid Evangelia¹,Zafeiriou Efterpi²,Georgiou Sophia³,Roussaki-Schulze Angeliki-Viktoria²,Spiliopoulos Theofanis³,Vryzaki Eleftheria³,Oikonomou Chrysa³,Drongoula Ourania⁴,Boziou Maria⁴,Goudouras Georgios²,Sfaelos Konstantinos⁵,Apalla Zoi⁴,Lazaridou Elisavet⁴

Affiliation:

1. 2nd Department of Dermatology and Venereology, ATTIKON University Hospital, Athens, Greece

2. Department of Dermatology, University General Hospital Larissa, University of Thessaly, Larissa, Greece

3. Department of Dermatology, Medical School, General University Hospital, University of Patras, Greece

4. 2nd Department of Dermatology-Venereology, Aristotle University School of Medicine, Thessaloniki, Greece

5. LEO Pharma Hellas, Dermatology, Athens, Greece

Funder

LEO Pharma

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2022.2110836

Reference25 articles.

1. European Medicines Agency. Summary of product characteristics: Kyntheum 210 mg solution for injection in pre-filled syringe2017. Available from: https://www.ema.europa.eu/en/documents/product-information/kyntheum-epar-product-information_en.pdf.

2. Rapid onset of action in patients with moderate-to-severe psoriasis treated with brodalumab: A pooled analysis of data from two phase 3 randomized clinical trials (AMAGINE-2 and AMAGINE-3)

3. Brodalumab in the treatment of chronic plaque psoriasis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Effectiveness of Brodalumab for the Treatment of Moderate-To-Severe Psoriasis: A Real-Life Multicenter Study of Up to 3 Years in a Real-Life Italian Cohort;Dermatology Practical & Conceptual;2024-04-30

2. Real-world outcomes and drug survival of brodalumab: results from the German Psoriasis Registry PsoBest;Journal of Dermatological Treatment;2024-04-18

3. Real‐world data on the effectiveness of brodalumab in patients with moderate‐to severe plaque psoriasis in the Greek clinical setting (the BrIDGE study);Journal of the European Academy of Dermatology and Venereology;2024-02-03

4. Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic;Dermatology and Therapy;2023-11-30